Valeo Pharma Inc. (VPHIF) Financials

VPHIF Assets vs Liabilities
DateAssetsLiabilities
July 31, 2024 32.2 million 68.8 million
April 30, 2024 34.6 million 64.9 million
Jan. 31, 2024 40.4 million 65.0 million
Oct. 31, 2023 41.2 million 59.0 million

VPHIF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
July 31, 2024 451000 28000
April 30, 2024 -3.6 million 47000
Jan. 31, 2024 1.4 million 194000
Oct. 31, 2023 -7.7 million 109000

VPHIF Net Income

No data available :(

VPHIF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
July 31, 2024 7.1 million 16.7 million 1.4 million
April 30, 2024 6.9 million 19.9 million 1.4 million
Jan. 31, 2024 9.6 million 25.5 million 1.4 million
Oct. 31, 2023 7.5 million 42.8 million 1.4 million

VPHIF Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
July 31, 2024 98.7 million
April 30, 2024 98.7 million
Jan. 31, 2024 86.1 million
Oct. 31, 2023 94.0 million

VPHIF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
July 31, 2024 - - 4.4 million 742000
April 30, 2024 29032 - 4.8 million 1.4 million
Jan. 31, 2024 37212 - 5.1 million 1.8 million
Oct. 31, 2023 3.6 million - 5.3 million 1.8 million

VPHIF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
July 31, 2024 9.1 million 9.2 million
April 30, 2024 10.3 million 11.4 million
Jan. 31, 2024 10.1 million 11.4 million
Oct. 31, 2023 9.5 million 12.5 million

VPHIF

Price: $0

52 week price:
0.00
0.12

Earnings Per Share: -0.27 USD

Exchange: PNK

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 9866

Links: